濮阳东方医院割包皮可靠(濮阳东方医院男科治阳痿价格标准) (今日更新中)

INDIANAPOLIS — The U.S. Food and Drug Administration on Monday granted emergency use authorization to Eli Lilly and Company's experimental COVID-19 antibody treatment bamlanivimab.According to a statement from the company, the drug is authorized for the treatment of mild to moderate COVID-19 in adults and pediatric patients 12 years and older with a positive COVID-19 test who are at high risk for progressing to severe COVID-19 and/or hospitalization. Lilly said in a statement the drug should be administered as soon as possible after a positive COVID-19 test and within 10 days of symptom onset. The authorization allows for the distribution and emergency use of bamlanivimab, which is administered via a single intravenous infusion."This emergency authorization allows us to make bamlanivimab available as a COVID-19 treatment for recently diagnosed, high-risk patients — adding a valuable tool for doctors fighting the now-increasing burden of this global pandemic," David A. Ricks, Lilly's chairman and CEO, said. "The rapid development and availability of bamlanivimab could not have been achieved without the relentless work of our Lilly team, collaboration across the industry and the urgent work being done by the government to ensure appropriate allocation to patients who need it the most."The emergency use authorization is based on data from BLAZE-1, a randomized, double-blind, placebo-controlled Phase 2 study in patients with recently diagnosed mild to moderate COVID-19 in the outpatient setting. Patients treated with the drug showed reduced viral load and rates of symptoms and hospitalization, Lilly said in the statement. Infusion reactions and other allergic hypersensitivity events have been reported, Lilly said. The emergency use authorization includes a warning for hypersensitivity including anaphylaxis and infusion-related reactions.Lilly said the drug is not authorized for use in patients who are hospitalized due to COVID-19 or who require oxygen therapy due to COVID-19 or who require an increase in baseline oxygen flow rate due to COVID-19 in those on chronic oxygen therapy due to underlying non-COVID-19 related comorbidity."The BLAZE-1 data show bamlanivimab, when given early in the disease course, may help patients clear the virus and reduce COVID-related hospitalizations, supporting our belief that neutralizing antibodies can be an important therapeutic option for patients fighting this virus," Daniel Skovronsky, M.D., Ph.D., Lilly's chief scientific officer and president of Lilly Research Laboratories, said. "We're proud of the speed with which we have been able to bring patients this therapy specifically designed to treat COVID-19. We thank those who have contributed to this medical advancement, particularly the clinical trial investigators and participants around the country." This article was written by Bob Blake for WRTV. 2906

ABBOTT PARK, Ill. – As the coronavirus continues to spread and the need for more testing grows with it, labs across the U.S. are racing to get approval for their tests for COVID-19. The company Abbott is one of them. “Abbott was able to get an emergency use authorization for a new test, molecular test for the SARS-coronavirus-2,” said John Hackett, Jr., the Divisional Vice President of Applied Research and Technology at Abbott. Researchers inside their Illinois lab created a test that can be used with the company’s testing system, called “m2000 RealTime.” That’s key because the company says that system is already widely available in hospitals and testing labs around the country. “These are in hospitals and academic centers and this is where the test volume is,” Hackett said. The speed in regulatory approval from the FDA for the test was unprecedented. The company said that, normally, it can take several years to get a test approved; this one happened in a matter of weeks. Their testing system can run through 470 patient tests per day. “This is a massive impact when you think about trying to get results back to the physicians,” Hackett said. “This is actionable information - either a person's infected or they're not.” About 150,000 tests are now on their way to hospitals and labs in 18 states – including New York, California and Washington – some of the hardest hit by COVID-19. The company plans to be producing a million tests a week by the end of this month. Other companies, including those in California and Texas, have similar authorizations from the FDA and are hoping to provide more tests. “The key thing here is to get to a point where we can change the trajectory, reduce the trajectory, reduce the number of new infections that are occurring,” Hackett said.It’s a change they hope might put a dent in the coronavirus pandemic. 1872

The Federal Trade Commission said Americans should be wary if they receive a phone call regarding their stimulus check. Amid the COVID-19 pandemic, the US government issued ,200 checks to millions of Americans with a number of businesses closed. The FTC is warning that scammers could potentially try to trick you out of your personal information. The agency says that fraudsters rig caller ID to make the number appear to come from a government hotline.“Government agencies usually will not call or email you — especially about something related to money. They almost always contact you by US mail,” the FTC said.The IRS is sending letters to Americans as a confirmation for receiving the stimulus check.The FTC says that scammers will claim to be calling over something such as Medicare, Social Security, or in this case, your stimulus check, and will ask for personal information to verify.“If you get a call or email from the IRS or any government agency asking you for personal information or money, that’s a scam. Hang up the phone or delete the email,” the FTC said.If you have questions about your stimulus check, you can call an IRS hotline at 800-919-9835.The IRS said earlier this month that 159 million Americans have received a stimulus check. The IRS is still working on sending out the remaining checks to qualified Americans. 1367

For the ladies in this gym, age isn't the number that matters most. "I’m going to be building up to 200. I want to get that done before I’m 80 years old,” says 78-year-old Bonnie Thurston on how much she can deadlift. Thurston says she’s been active her whole life, but never thought she would powerlift. Seven years ago, Thurston struggled with osteoporosis, a condition in which bones become weak and brittle, increasing risk of fractures. Then, Thurston found a powerlifting group for seniors. "I now weigh more than I weighed when I started this, but I wear the same size clothes, and the reason is I have stronger bones and larger bones and more muscle in my body than I did when I started this," she says. These group of seniors deadlift; they bench and they pull sleds. And while Thurston is doing all of this, she pushes 80. Thurston is not even the oldest person at the gym. Edith Murway-Traina is a member and is 97 years old. “I've always had muscles, I just had to learn to use them," she says. Bill Beekley leads the group. He's trained powerlifters since the 90s. "Don't be intimidated by what these ladies are doing, because they all started just moving their bodies," Beekley says. He says lifting correctly can help increase bone density and fight conditions like osteoporosis. It also helps these women in everyday life. "It's very functional,” the instructor says. “Some say they can carry their groceries a little easier now and don't need help getting groceries in an out of the car.” For 97-year-old Murway-Traina, she says that movement is so important as she nears 100. “The more you move, the more exercise you get, the more your body responds,” she says. Murway-Traina says she was nervous about the idea of powerlifting at first, but she now does it three times a week. "When you start being too old for something, you are too old for something, you have to know you are capable of doing what you want to make yourself do," Murway-Traina says. Research agrees. A JAMA study found physical activity in later life is linked to a lower risk of dying, even in older people who haven't been very active.Murway-Traina wants other seniors not to let the weight of getting older stop them from giving this a try. 2253

He was a former cop with a little-known story of infiltrating the KKK back in the 1970’s, until an Oscar-winning film thrust him into the national spot light.Now, Ron Stallworth’s story is known to many. “I never imagined anything like this happening when I began this, writing this book,” Stallworth says. “I just want to tell a story.”And Stallworth’s real life meets today's real life. The movie BlacKkKlansman ends with real footage from the deadly “Unite the Right” rally in Charlottesville, Virginia, as well as President Donald Trump’s comments afterwards, saying there were “very find people on both sides.” Stallworth believes the president's words are, in part, why his story still resonates so much today. “He had an opportunity to be the moral conscience of this country in that precise defined moment, and he chose to equate hate with non-violent protesters,” Stallworth says. Stallworth views today's alt-right protesters in the same light as KKK members of decades past. “The alt-right doesn't sport white hoods and white sheets. They wear suit coats. They look like business people,” he says. “They don't have the stereotypical image of the southern racists that many of us grew up grew up on in the movie.” That's why he believes diversity in law enforcement, and connection with the community, is more important now than ever. “If you have a systemic evil in an organization like racism, one of the best ways to fight it is to become part of the organization fight it from within,” Stallworth says. “And that's what I was doing back at back in the day. That's where a lot of people are doing these days.” 1639

来源：资阳报